Rupp, T.; Debasly, S.; Genest, L.; Froget, G.; Castagné, V.
Therapeutic Potential of Fingolimod and Dimethyl Fumarate in Non-Small Cell Lung Cancer Preclinical Models. Int. J. Mol. Sci. 2022, 23, 8192.
https://doi.org/10.3390/ijms23158192
AMA Style
Rupp T, Debasly S, Genest L, Froget G, Castagné V.
Therapeutic Potential of Fingolimod and Dimethyl Fumarate in Non-Small Cell Lung Cancer Preclinical Models. International Journal of Molecular Sciences. 2022; 23(15):8192.
https://doi.org/10.3390/ijms23158192
Chicago/Turabian Style
Rupp, Tristan, Solène Debasly, Laurie Genest, Guillaume Froget, and Vincent Castagné.
2022. "Therapeutic Potential of Fingolimod and Dimethyl Fumarate in Non-Small Cell Lung Cancer Preclinical Models" International Journal of Molecular Sciences 23, no. 15: 8192.
https://doi.org/10.3390/ijms23158192
APA Style
Rupp, T., Debasly, S., Genest, L., Froget, G., & Castagné, V.
(2022). Therapeutic Potential of Fingolimod and Dimethyl Fumarate in Non-Small Cell Lung Cancer Preclinical Models. International Journal of Molecular Sciences, 23(15), 8192.
https://doi.org/10.3390/ijms23158192